Randle Reece - AMN Healthcare IR Contact Officer
| AMN Stock | USD 19.54 0.82 4.03% |
Executive
Randle Reece is IR Contact Officer of AMN Healthcare Services since 2017.
| Tenure | 9 years |
| Address | 2999 Olympus Boulevard, Dallas, TX, United States, 75019 |
| Phone | 866 871 8519 |
| Web | https://www.amnhealthcare.com |
AMN Healthcare Management Efficiency
The company has Return on Asset of 0.0117 % which means that on every $100 spent on assets, it made $0.0117 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.359) %, meaning that it generated no profit with money invested by stockholders. AMN Healthcare's management efficiency ratios could be used to measure how well AMN Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. As of the 13th of February 2026, Return On Tangible Assets is likely to grow to -0.11. In addition to that, Return On Capital Employed is likely to grow to -0.05. At this time, AMN Healthcare's Total Assets are very stable compared to the past year. As of the 13th of February 2026, Non Current Assets Total is likely to grow to about 2.2 B, while Other Current Assets are likely to drop about 39.9 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Joaquim Marques | Ginkgo Bioworks Holdings | N/A | |
| Patrick Boyle | Ginkgo Bioworks Holdings | N/A | |
| David Lim | Evolent Health | N/A | |
| Susan Stansfield | Compass Pathways Plc | N/A | |
| Stephanie Greene | Airsculpt Technologies | N/A | |
| Scott Gleason | Myriad Genetics | 45 | |
| Jordan Silvergleid | Evolent Health | N/A | |
| Kari Jeschke | Replimune Group | N/A | |
| Andrew Schwendenman | Replimune Group | 50 | |
| David Hammer | Myriad Genetics | N/A | |
| Emily Rafferty | Evolent Health | 43 | |
| Anna Wagner | Ginkgo Bioworks Holdings | N/A | |
| Steven CPA | Ginkgo Bioworks Holdings | N/A | |
| Karen Tepichin | Ginkgo Bioworks Holdings | N/A | |
| Mario Ramos | Evolent Health | 53 | |
| Becky Buzzeo | Maravai Lifesciences Holdings | N/A | |
| Benjamin Wheeler | Myriad Genetics | 43 | |
| Jennifer Fox | Myriad Genetics | 52 | |
| Mercedes Kelemen | Butterfly Network | N/A | |
| Jennifer Rodriguez | Nutex Health | N/A | |
| Jonathan Weinberg | Evolent Health | 53 | |
Management Performance
| Return On Equity | -0.36 | ||||
| Return On Asset | 0.0117 |
AMN Healthcare Services Leadership Team
Elected by the shareholders, the AMN Healthcare's board of directors comprises two types of representatives: AMN Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AMN. The board's role is to monitor AMN Healthcare's management team and ensure that shareholders' interests are well served. AMN Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AMN Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| R Harris, Independent Director | ||
| Cole Edmonson, Chief Experience and Clinical Officer | ||
| Nishan Sivathasan, Division Solutions | ||
| Mark Foletta, Independent Director | ||
| Landry Seedig, Group President and Chief Operating Officer, Nurse and Allied Solutions | ||
| Julie Fletcher, Chief Officer | ||
| Randle Reece, IR Contact Officer | ||
| Kelly Rakowski, Group President and Chief Operating Officer, Strategic Talent Solutions | ||
| Jeffrey Knudson, Chief Financial Officer, Chief Accounting Officer | ||
| Meredith Lapointe, Chief Officer | ||
| Patrick McCall, Chief Officer | ||
| Brian Scott, Chief Financial Officer, Chief Accounting Officer, Treasurer | ||
| Teri Fontenot, Independent Director | ||
| Whitney Laughlin, Corporate Officer | ||
| Christopher Schwartz, Principal Financial Officer | ||
| Denise Jackson, Senior Vice President, General Counsel, Secretary | ||
| Michael Johns, Independent Director | ||
| Julie Purinton, Division Nurse | ||
| Susan Salka, CEO and President Director and Member of Executive Committee | ||
| James Taylor, Group President and Chief Operating Officer for Physician & Leadership Solutions | ||
| Kimberly Martini, Division Solutions | ||
| Jorge Caballero, Independent Director | ||
| Martha Marsh, Independent Director | ||
| Kerry Perez, Chief Officer | ||
| Mark Hagan, Chief Information Office and Digital Officer, Executive Officer | ||
| Robin Johnson, Group Solutions | ||
| Sylvia TrentAdams, Independent Director | ||
| Douglas Wheat, Independent Chairman of the Board | ||
| Caroline Grace, CEO President | ||
| Carolyn Kenny, Chief Officer | ||
| Tomya Watt, Chief Officer | ||
| Jeff Decker, Division Solutions | ||
| Daphne Jones, Independent Director |
AMN Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AMN Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.36 | ||||
| Return On Asset | 0.0117 | ||||
| Profit Margin | (0.10) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 1.58 B | ||||
| Shares Outstanding | 38.41 M | ||||
| Shares Owned By Insiders | 0.91 % | ||||
| Shares Owned By Institutions | 99.09 % | ||||
| Number Of Shares Shorted | 1.95 M | ||||
| Price To Earning | 12.02 X |
Pair Trading with AMN Healthcare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AMN Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AMN Healthcare will appreciate offsetting losses from the drop in the long position's value.Moving together with AMN Stock
Moving against AMN Stock
| 0.66 | HUM | Humana Inc | PairCorr |
| 0.64 | UNH | UnitedHealth Group CDR | PairCorr |
| 0.63 | UNH | UnitedHealth Group Aggressive Push | PairCorr |
| 0.55 | REG | Regis Healthcare | PairCorr |
| 0.46 | UHS | Universal Health Services | PairCorr |
The ability to find closely correlated positions to AMN Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AMN Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AMN Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AMN Healthcare Services to buy it.
The correlation of AMN Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AMN Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AMN Healthcare Services moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AMN Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AMN Healthcare Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Will Health Care Providers & Services sector continue expanding? Could AMN diversify its offerings? Factors like these will boost the valuation of AMN Healthcare. If investors know AMN will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AMN Healthcare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 3.213 | Earnings Share (7.20) | Revenue Per Share | Quarterly Revenue Growth (0.08) | Return On Assets |
AMN Healthcare Services's market price often diverges from its book value, the accounting figure shown on AMN's balance sheet. Smart investors calculate AMN Healthcare's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since AMN Healthcare's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that AMN Healthcare's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AMN Healthcare represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, AMN Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.